AA
Ascentage Pharma Group International
AAPG · NASDAQ
$15.86 -0.31% (-$0.05)
1M -9.87%
Market Cap ¥2.34B
P/E Ratio -
Div. Yield -
ROE 171.96%
Piotroski F-Score Weak
2/9Valuation
68 /100
Cheap P/B 1.77x
P/S 4.19x
PEG N/A
Growth
100 /100
Growing Book val. growth 48.02%
Rev. growth 38.61%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 215.17%
Op. margin 211.14%
Gross margin 76.41%
Quality
2 /100
Poor Asset turnover 0.14x
ROA 30.48%
ROIC 33.45%
Debt
37 /100
Moderate Current ratio 1.79x
Int. coverage -22.42x
Debt/Equity 1.49x
Stability
26 /100
Unstable Profitable years 0
EPS volatility 122.93%
Beta 0.66x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o AAPG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Dajun Yang
Employees
767
Headquarters
Suzhou
Nadchodzące wydarzenia
31 MAR
Earnings
Upcoming earnings report